Liraglutide [liraglutid]
- Terms
-
Victoza
-
NN 2211
NN-2211
NN2211
Saxenda
Victoza
An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.
- DUI
- D000069450 MeSH Browser
- CUI
- M0405743
- History note
- 2016 (2001)
- Public note
- 2016; LIRAGLUTIDE was indexed under GLUCAGON-LIKE PEPTIDE 1 2005-2015; and under GLUCAGON 2001-2005
Allowable subheadings
- AD
- administration & dosage 134
- AE
- adverse effects 48
- AA
- analogs & derivatives 9
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 6
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 2
- PK
- pharmacokinetics 14
- PD
- pharmacology 101
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 181
- TO
- toxicity
- UR
- urine
IDegLira Chemical MeSH Browser
Xultophy Chemical MeSH Browser